{"result": {"id": "chatcmpl-526", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "Bevacizumab is a drug used in the treatment of myopic choroidal neovascularization (CNV). It is an anti-VEGF agent, meaning it inhibits the action of vascular endothelial growth factor (VEGF), which plays a role in angiogenesis.  It is also known as a VEGF inhibitor and is used in anti-angiogenesis therapy. \n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743089690, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 73, "prompt_tokens": 182, "total_tokens": 255, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are a helpful assistant responsible for generating a comprehensive summary of the data provided below.\nGiven one or two entities, and a list of descriptions, all related to the same entity or group of entities.\nPlease concatenate all of these into a single, comprehensive description. Make sure to include information collected from all the descriptions.\nIf the provided descriptions are contradictory, please resolve the contradictions and provide a single, coherent summary.\nMake sure it is written in third person, and include the entity names so we have the full context.\n\n#######\n-Data-\nEntities: \"BEVACIZUMAB\"\nDescription List: [\"Anti-VEGF agent used in anti-angiogenesis therapy for myopic CNV\", \"Drug name\", \"Drug name for VEGF inhibitor\", \"Drug used in treatment for retinal neovascularization\"]\n#######\nOutput:\n", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 500, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_summarize_47215d900ec8bf16dce7ecb1ed9a58344f1d7baf7bcd458d5fb23e94af8afd39_v2"}